This report was first published by Endpoints News. To see the original version, click here
Competition from China was top of mind today for executives and leadership across San Francisco.
Biogen is meeting with companies that it initially spoke with during a trip to China last month, strategy chief Adam Keeney told Endpoints News. And ARCH Venture Partners co-founder Bob Nelsen said US biotechs need to work harder to keep up.
您已阅读4%（427字），剩余96%（10671字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。